Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 806,210 | 359,388 | 540,865 | 438,154 | 347,868 |
| Marketable Securities | N/A | N/A | N/A | 7,034 | 20,141 |
| Receivables | 282,722 | 267,397 | 244,288 | 221,293 | 212,720 |
| Inventories | 94,108 | 92,906 | 81,386 | 78,302 | 75,222 |
| Income taxes - deferred | 19,127 | 19,048 | 19,132 | 19,995 | 20,863 |
| TOTAL | $1,276,161 | $811,934 | $941,270 | $817,356 | $700,395 |
| Non-Current Assets | |||||
| PPE Net | 164,568 | 165,763 | 165,852 | 164,153 | 163,763 |
| Intangibles | 931,201 | 941,318 | 171,243 | 172,844 | 174,052 |
| Other Non-Current Assets | 85,680 | 98,449 | 116,386 | 150,689 | 141,365 |
| TOTAL | $1,181,449 | $1,205,530 | $453,481 | $487,686 | $479,180 |
| Total Assets | $2,457,610 | $2,017,464 | $1,394,751 | $1,305,042 | $1,179,575 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,000 | 108,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 23,752 | 16,023 | 16,029 | 14,372 | 13,446 |
| Accrued Expenses | 270,573 | 206,863 | 183,624 | 172,739 | 141,248 |
| Other current liabilities | 5,183 | 3,914 | 10,227 | 9,067 | 17,479 |
| TOTAL | $375,162 | $353,677 | $227,785 | $211,244 | $187,780 |
| Non-Current Liabilities | |||||
| Long Term Debt | 180,000 | 247,000 | N/A | N/A | N/A |
| Deferred Revenues | 26,812 | 17,983 | 17,905 | 13,636 | 13,925 |
| aiOther Non-Current Liabilities | 152,754 | 147,997 | 32,471 | 27,780 | 27,956 |
| TOTAL | $332,754 | $450,507 | $32,474 | $38,070 | $38,293 |
| Total Liabilities | $707,916 | $804,184 | $260,259 | $249,314 | $226,073 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 193,060 | 186,924 | 185,993 | 185,147 | 184,530 |
| Common Shares | 19 | 19 | 19 | 19 | 18 |
| Retained earnings | -46,948 | -83,206 | -128,619 | -176,789 | -242,359 |
| Other shareholders' equity | 16,866 | 7,880 | 4,503 | -2,780 | -19,303 |
| TOTAL | $1,749,694 | $1,213,280 | $1,134,492 | $1,055,728 | $953,502 |
| Total Liabilities And Equity | $2,457,610 | $2,017,464 | $1,394,751 | $1,305,042 | $1,179,575 |